Please try another search
Ryan D. Maynard, a director at Iovance Biotherapeutics Inc. (NASDAQ:IOVA), recently sold 50,000 shares of common stock, generating a total of $503,000. The shares were sold at an average price of...
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company focused on developing and commercializing novel cancer immunotherapies, has been making significant strides in the oncology space....
Cryoport Inc . (NASDAQ: NASDAQ:CYRX), a global leader in life sciences supply chain solutions, has maintained its full-year revenue guidance for 2024, citing solid growth in its Life Sciences...
The markets did very well on Thursday, despite the afternoon profit taking that took some of the gains. A lot of stocks we follow are doing great. Let’s take a look at a few of them...
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing...
Investors in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 21, 2019 $12.50 Call had some...
Instrument Type
Region
Sector
Industry
Date
Category
Provider